Cogent Biosciences, Inc. (COGT)
34.05
+0.11
(+0.32%)
USD |
NASDAQ |
May 27, 15:41
Cogent Biosciences Free Cash Flow : -286.27M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Syndax Pharmaceuticals, Inc. | -278.35M |
| Vera Therapeutics, Inc. | -293.81M |
| Spyre Therapeutics, Inc. | -185.87M |
| Nuvalent, Inc. | -312.79M |
| Praxis Precision Medicines, Inc. | -282.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -86.88M |
| Cash from Investing (Quarterly) | -36.46M |
| Cash from Financing (Quarterly) | 52.54M |
| Free Cash Flow Per Share (Quarterly) | -0.5382 |
| Free Cash Flow to Equity (Quarterly) | -87.19M |
| Free Cash Flow to Firm (Quarterly) | -86.12M |
| Free Cash Flow Yield | -5.98% |